The Placebo Effect May Involve Modulating Drug Bioavailability

NACompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Placebo EffectDrug Half LifePharmacokinetics
Interventions
DRUG

Caffeine, paracetamol, cephalexin, or ibuprofen

The study has 4 sub-parts (one for each of 4 drugs), each sub-part has a crossover design. In this arm, the volunteer will be given one oral dose of 300 mg caffeine, 500 mg paracetamol, 500 mg cephalexin, or 400 mg ibuprofen and will be told that they are receiving the active drug.

DRUG

Placebo (caffeine, paracetamol, cephalexin, or ibuprofen)

The study has 4 sub-parts (one for each of 4 drugs), each sub-part has a crossover design. In this arm, the volunteer will be given one oral dose of 300 mg caffeine, 500 mg paracetamol, 500 mg cephalexin, or 400 mg ibuprofen and will be told that they are receiving a placebo.

Trial Locations (1)

11211

King Faisal Specialist Hospital & Research Center, Riyadh

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER

NCT01501747 - The Placebo Effect May Involve Modulating Drug Bioavailability | Biotech Hunter | Biotech Hunter